Post transplantation restenosis, vaso-occlusion complications, and rejection contribute to the increased mortality of patients that undergo cardiac transplantation. The post-transplantation use of ...

Am J Health Syst Pharm. 2010;67(10):806-809. The patient had no signs or symptoms of retroperitoneal hematoma until she became acutely hypotensive approximately 48 hours after the administration of ...

Taken together, a clinical predicament arises: how to treat de novo TE patients experiencing concomitant severe thrombocytopenia owing to the administration of high-dose chemotherapy. The continuation ...

Purpose. A case of fatal retroperitoneal hematoma that developed after enoxaparin administration in a woman with paroxysmal atrial flutter and chest pain is reported. Summary. A 63-year-old, 74-kg, ...

Advanced pancreatic cancer (APC), in addition to its high mortality, accounts for the highest rates of venous thromboembolic events (VTEs). Enoxaparin, a low–molecular weight heparin, is effective in ...

A more selective risk-stratified approach to postpartum enoxaparin (Lovenox) thromboprophylaxis for venous thromboembolism (VTE) was linked to reduced rates of wound hematomas without increasing the ...

Apotex recalled two batches of mislabeled enoxaparin sodium syringes Enoxaparin is used to prevent blood clots It should not be stopped without doctors' advice A ...

The US Food and Drug Administration (FDA) decision to approve a generic heparin derivative without clinical safety or efficacy data raises the possibility that clinical trials might not always be ...

SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday. The FDA ...

The FDA has granted approval to Amphastar's generic version of Lovenox (enoxaparin sodium), Watson Pharmaceuticals has announced. The low molecular weight heparin will be sold by Watson under an ...